We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intravascular Ultrasound for Hepatocellular Carcinoma Staging

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2007 by University Hospital, Geneva.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00474734
First Posted: May 17, 2007
Last Update Posted: May 17, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital, Geneva
May 15, 2007
May 17, 2007
May 17, 2007
May 2007
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Intravascular Ultrasound for Hepatocellular Carcinoma Staging
Intravascular Ultrasound for the Staging of Hepatocellular Carcinoma: a Pilot Study

To diagnose hepatocellular carcinoma (HCC) and to determine the extent of the disease, a triphasic CT scan or a magnetic resonance imaging are required. The characterization of hepatic nodules is more difficult when the HCC lesions have a diameter of less than 2 cm.

Since accuracy in the assessment of the number and the size of HCC nodules, as well as of the invasion of blood vessels is crucial to determine outcome after liver transplantation due to tumour recurrence, there is a need for techniques with a higher definition potential.

As a consequence, to improve outcome and to optimize organ allocation, patients on the liver transplantation waiting list might benefit from intravascular ultrasound as an additional examination to complete the pre-transplant tumour staging process.

Not Provided
Observational
Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Hepatocellular Carcinoma
Device: Intravascular ultrasound of the liver
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
Not Provided
September 2007
Not Provided

Inclusion Criteria:

  • hepatocellular carcinoma nodules
  • patient on liver transplantation waiting list
  • written informed consent

Exclusion Criteria:

  • thrombosis of hepatic veins or vena cava
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
 
NCT00474734
07-063
Yes
Not Provided
Not Provided
Not Provided
University Hospital, Geneva
Not Provided
Study Chair: Antoine Hadengue, Prof. University Hospital, Geneva
University Hospital, Geneva
May 2007